Widespread and accessible testing is an essential component of our nation’s response to the Covid-19 pandemic. Yet while testing continues to expand across the U.S., with nearly 90 million tests ...

GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights over traditional panel testing. The company achieved a significant turnaround, becoming cash flow ...

PHILADELPHIA, Nov. 23, 2010 (GLOBE NEWSWIRE) -- Global Strategy Board, the independent international research firm and a leading provider of ETF databases for institutions and individuals has ...

Effective strategies are needed to facilitate the prompt diagnosis and treatment of tuberculosis in countries with a high burden of the disease. We conducted a cluster-randomized trial in which ...